2026 Radionuclide Theranostics for the Management of Cancer Gordon Research Conference and Gordon Research Seminar
About This Grant
PROJECT SUMMARY The 2026 Gordon Research Conference (GRC) on Radionuclide Theranostics for the Management of Cancer, along with the preceding Gordon Research Seminar (GRS), is a premier scientific meeting designed to advance the field of radionuclide-based diagnostics and therapeutics for cancer treatment. Set within the retreat-style format of GRC, the conference will convene a diverse, interdisciplinary community of academic and industry scientists, physicists, oncologists, clinicians, and regulatory leaders to address critical barriers limiting the clinical translation, global accessibility, and optimal use of theranostics in cancer medicine. The objectives of the conference are fourfold: foster cross-disciplinary collaboration, accelerate translational research, support early- career scientists, and promote scientific rigor through the exchange of unpublished data and open dialogue. The meeting’s theme, “Theranostics Reimagined: Interrogating Biology, Empowering Translation,” reflects its focus on three foundational challenges: limited access to radioligand therapies worldwide, the complexity of cancer biology and patient stratification, and gaps in understanding dosimetry, immunologic interactions, and enhanced targeting strategies that lead to improved efficacy. These objectives will be met through nine formal topical sessions, poster presentations, provocative discussions, and dedicated networking opportunities that encourage interactive engagement among participants. The GRS will provide a dedicated platform for trainees to present cutting-edge research and receive mentorship. With its progressive agenda and intimate format, this GRC is uniquely positioned to shape the future of radionuclide theranostics and precision oncology, and aligns closely with National Cancer Institute’s mission to improve outcomes and quality of life for patients through research- driven advances in cancer care.
Grant Summary
2026 Radionuclide Theranostics for the Management of Cancer Gordon Research Conference and Gordon Research Seminar is a NCI - National Cancer Institute grant providing up to $4K for university, nonprofit, healthcare org. Applications are due 2027-06-30 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $4K
2027-06-30
- 1Confirm your organization is eligible for 2026 Radionuclide Theranostics for the Management of Cancer Gordon Research Conference and Gordon Research Seminar from NCI - National Cancer Institute, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NCI - National Cancer Institute before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NCI - National Cancer Institute's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
2026 Radionuclide Theranostics for the Management of Cancer Gordon Research Conference and Gordon Research Seminar: Frequently Asked Questions
Who is eligible for the 2026 Radionuclide Theranostics for the Management of Cancer Gordon Research Conference and Gordon Research Seminar?
2026 Radionuclide Theranostics for the Management of Cancer Gordon Research Conference and Gordon Research Seminar is offered by NCI - National Cancer Institute and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the 2026 Radionuclide Theranostics for the Management of Cancer Gordon Research Conference and Gordon Research Seminar provide?
2026 Radionuclide Theranostics for the Management of Cancer Gordon Research Conference and Gordon Research Seminar provides up to $4K per award from NCI - National Cancer Institute. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the 2026 Radionuclide Theranostics for the Management of Cancer Gordon Research Conference and Gordon Research Seminar deadline?
Applications for 2026 Radionuclide Theranostics for the Management of Cancer Gordon Research Conference and Gordon Research Seminar are due 2027-06-30 (open). Because deadlines can change, verify the date with the funder, NCI - National Cancer Institute, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the 2026 Radionuclide Theranostics for the Management of Cancer Gordon Research Conference and Gordon Research Seminar?
To apply for 2026 Radionuclide Theranostics for the Management of Cancer Gordon Research Conference and Gordon Research Seminar, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NCI - National Cancer Institute.